Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cerebrolysin as Add-on to Mechanical Thrombectomy in Acute Ischemic Stroke
NCT04904341Phase 3Unknown
- Sponsor
- Military Institute of Medicine – National Research Institute
- Start
- Jan 2021
- Primary completion
- Dec 2023
- Modality
- Native Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of cerebrolysin in ischemic stroke, sponsored by Military Institute of Medicine – National Research Institute. Status: unknown.
02
Drugs
cerebrolysin
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT04904341.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04904341.